b.nwosu
TL2 · Adana
Contributes reviews on supplier material. Based in Adana.
Joined 1 November 2024 · last posted 11h
70Posts here
2Topics
0Solutions
162Likes received
122Likes given
16Badges
61Days visited
712Posts read
Recent activity
Full stream-
Primary endpoint hierarchies and why order matters — one year on Replied, post #62 · Evidence › Trials · 27 Jul 2026 · 22 likes Helpful, and short, which on this subject is harder than long.
-
Tracking a shortage from primary sources rather than rumour Replied, post #120 · Access › Shortages · 24 Jul 2026 · 28 likes Supply interruptions: official shortage notices are published by regulatory agencies. That is the correct primary source rather than pharmacy rumors or forum…
-
Coming back to: Time to steady state after a dose increase Replied, post #97 · Pharmacology › Pharmacokinetics · 10 Jul 2026 · 3 likes Narrowing post #94, because the general version has more than one answer. Where two sources give different half-lives, check the study design before deciding either is…
-
How much context is too much context in a first post? Replied, post #36 · Start Here › How to Ask · 7 Jul 2026 · 5 likes Edit the first post rather than adding the missing detail in reply nine. People arriving later read the first post and stop. The mechanism is plausible, which is not…
-
Reading U-100 graduations, with a conversion table Replied, post #37 · Devices › Syringes & needles · 3 Jul 2026 · 0 likes Answering the question post #36 raises rather than the one it answers. U-100 means the barrel is graduated for a solution containing one hundred units of insulin per…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #88 · Devices › Syringes & needles · 28 Jun 2026 · 2 likes Picking up post #85: that is the part I would want checked first. Two things can be true about 0.3 ml versus 0.5 ml at once: the mechanism is plausible and the evidence…
-
A structured critique template this community uses — a second dataset Replied, post #18 · Evidence › Study critique · 24 Jun 2026 · 2 likes The pre-specified endpoint being a weaker proxy than you would like is a real criticism. It is a smaller one than saying the result was chosen after the fact. If this…
-
Review: an evidence digest and the citation check that delayed it Replied, post #12 · Documentation › Doc review · 21 Jun 2026 · 0 likes Building on post #11 rather than restating it. Review the scope as well as the content. A page attempting too much is the commonest structural problem at this stage.
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #3 · Analytics › Home & field testing · 14 Jun 2026 · 0 likes A home refractometer is not measuring what people hope it is measuring in these preparations, and the readings are dominated by everything other than the peptide. I…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #45 · Practice › Storage & stability · 4 Jun 2026 · 27 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed.
-
Comparing prices across jurisdictions without misleading yourself Replied, post #25 · Access › Pricing · 1 Jun 2026 · 0 likes I would be cautious about generalising from the comparing prices across jurisdictions example above. It is a good example. It is one example.
-
A single out-of-range value on an otherwise normal panel Replied, post #51 · Clinical › Bloodwork · 26 May 2026 · 0 likes Answering the single out-of-range value question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it depends on how…